Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thierry Alcindor, M.D.

Concepts (280)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Sarcoma15202418012.310 Why?
Esophageal Neoplasms15202416541.560 Why?
Stomach Neoplasms11202414591.320 Why?
Soft Tissue Neoplasms7202311591.180 Why?
Antineoplastic Combined Chemotherapy Protocols272024117421.100 Why?
Fibromatosis, Aggressive220241261.040 Why?
Adenocarcinoma16202463450.950 Why?
Adenosarcoma12021360.740 Why?
Spinal Cord Neoplasms120222630.660 Why?
Immunotherapy5202446520.650 Why?
Pyrimidinones120223850.650 Why?
Polycythemia120191240.600 Why?
Peritoneal Neoplasms220227110.570 Why?
Pyridones120228090.530 Why?
Mesothelioma120228070.520 Why?
Anus Neoplasms320123290.520 Why?
Neurofibromatosis 1120215610.510 Why?
Universities120219930.500 Why?
Neoadjuvant Therapy8202428280.490 Why?
Quinazolines2201913710.460 Why?
Fluorouracil11202416420.460 Why?
Doxorubicin5202422240.450 Why?
Colonic Neoplasms2202325390.420 Why?
Endodermal Sinus Tumor12013530.410 Why?
Chromosomes, Human, Pair 22120133460.390 Why?
Neuroectodermal Tumors, Primitive120131360.390 Why?
Neoplasm Recurrence, Local7202392800.390 Why?
Liposarcoma, Myxoid22024600.370 Why?
Neoplasm Metastasis9202449150.370 Why?
Esophagectomy620244680.370 Why?
Chemotherapy, Adjuvant6202435140.360 Why?
Translocation, Genetic2201513930.360 Why?
Bone Neoplasms3202325290.340 Why?
Teratoma120134040.340 Why?
Leucovorin620196430.330 Why?
Neoplasm Staging82024111200.320 Why?
Organoplatinum Compounds520184070.300 Why?
Protein Kinase Inhibitors4202456720.300 Why?
Phenylurea Compounds320235290.300 Why?
Salvage Therapy1201412630.300 Why?
Neoplasms, Germ Cell and Embryonal120134910.290 Why?
Liposarcoma220222890.280 Why?
Antineoplastic Agents52023136420.260 Why?
Colorectal Neoplasms6201869380.250 Why?
Taxoids520166680.250 Why?
Venous Thromboembolism1201818660.250 Why?
Neoplasms, Second Primary1201310520.240 Why?
Humans7120247615960.240 Why?
Sulfonamides1201419790.240 Why?
Carcinoma, Small Cell120074200.240 Why?
Angiogenesis Inhibitors1201420480.230 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor120241140.230 Why?
Whole Body Imaging220242830.230 Why?
Antineoplastic Agents, Phytogenic120086210.230 Why?
Esophagogastric Junction520233470.230 Why?
Pyrimidines2201730280.220 Why?
Carcinoma, Squamous Cell4201440240.210 Why?
Tetrahydronaphthalenes12023860.210 Why?
Plasma Cells120065990.210 Why?
Radioimmunotherapy12002910.200 Why?
Carbolines120242960.200 Why?
Middle Aged4220242209210.200 Why?
Cisplatin6202416520.190 Why?
Antigens, CD20120022000.190 Why?
Antibiotics, Antineoplastic220176780.190 Why?
Yttrium Radioisotopes120021070.190 Why?
Fatal Outcome2202218350.190 Why?
Proto-Oncogene Proteins c-raf120222050.190 Why?
PUVA Therapy120011010.190 Why?
Anemia, Sideroblastic120021090.190 Why?
Extracorporeal Circulation120011810.180 Why?
Chondrosarcoma120232960.180 Why?
Canada7202321220.180 Why?
Aminopyridines220225730.180 Why?
Hemangiopericytoma12021710.180 Why?
Adult3620242212100.180 Why?
Pyridines3202328750.180 Why?
Hydrazines120222240.180 Why?
Paclitaxel1200817320.180 Why?
Solitary Fibrous Tumors12021670.170 Why?
Quinolines220247650.170 Why?
Female4320243927050.160 Why?
Deoxycytidine220218770.160 Why?
Sarcoma, Alveolar Soft Part12019430.160 Why?
Gene Fusion120223560.160 Why?
Acquired Immunodeficiency Syndrome1200721990.150 Why?
Male4020243608460.150 Why?
Retrospective Studies142024806470.150 Why?
Aged3220241693100.150 Why?
Osteosarcoma120238970.150 Why?
Survival Rate72024127230.140 Why?
Disease-Free Survival7201768150.140 Why?
Proto-Oncogene Proteins p21(ras)2202317450.140 Why?
Pancreatic Neoplasms3201953680.140 Why?
Truth Disclosure120214340.140 Why?
Triazoles120229030.140 Why?
Treatment Outcome162024646850.130 Why?
Ketones120171840.130 Why?
Propensity Score1202419130.130 Why?
Furans120172020.130 Why?
Lymphoma, B-Cell120029400.130 Why?
Quality of Life52023133670.120 Why?
Double-Blind Method72023123410.120 Why?
Histone Deacetylase 212015720.120 Why?
Pyrroles1202111250.120 Why?
Antibodies, Monoclonal3202091770.120 Why?
Dacarbazine120175590.120 Why?
Aged, 80 and over152023589840.120 Why?
Kaplan-Meier Estimate7201964840.120 Why?
Systemic Inflammatory Response Syndrome120196210.120 Why?
Histone Deacetylase Inhibitors220177740.110 Why?
Receptor, erbB-22202325570.110 Why?
Gastrointestinal Neoplasms120219540.110 Why?
Camptothecin220165910.110 Why?
Indazoles120143040.100 Why?
RNA-Binding Proteins1202218980.100 Why?
Tissue Banks120131840.100 Why?
Prognosis92024296290.100 Why?
Medical Oncology2202123210.100 Why?
Rectal Neoplasms1202111570.100 Why?
Oncolytic Virotherapy120185160.100 Why?
Young Adult122024592600.090 Why?
Scapula120131730.090 Why?
Multiple Pulmonary Nodules120131730.090 Why?
Benzodioxoles12011750.090 Why?
Perioperative Period120112500.090 Why?
Solitary Pulmonary Nodule120132780.080 Why?
Benzimidazoles120158580.080 Why?
Adaptation, Psychological1202026290.080 Why?
Maximum Tolerated Dose220248830.080 Why?
Deglutition Disorders120146250.080 Why?
Graft vs Host Disease1200130290.080 Why?
Enteral Nutrition120147940.080 Why?
Brain Neoplasms2202090320.070 Why?
Phosphoramide Mustards22017180.070 Why?
ras Proteins1201210540.070 Why?
Combined Modality Therapy5202085270.070 Why?
Drug Administration Schedule4201648530.070 Why?
Testicular Neoplasms120137990.070 Why?
Sirolimus1201315330.070 Why?
Leukemia, B-Cell12006840.060 Why?
Healthcare Disparities1202133580.060 Why?
Receptor, Macrophage Colony-Stimulating Factor12024940.060 Why?
Follow-Up Studies52024391060.060 Why?
Quebec120241410.060 Why?
TOR Serine-Threonine Kinases1201320570.060 Why?
Prevalence12021157330.060 Why?
Magnetic Resonance Imaging22024364260.060 Why?
Lymphoma, Mantle-Cell120062370.050 Why?
Health Services Accessibility1202154400.050 Why?
Pilot Projects1201686330.050 Why?
Vitamin B 6 Deficiency12002180.050 Why?
Chloramphenicol12002670.050 Why?
Cytotoxicity, Immunologic1200613510.050 Why?
Placebos2201616670.050 Why?
Lung Neoplasms22019133810.050 Why?
CD4-CD8 Ratio120011140.050 Why?
Palliative Care2201435980.050 Why?
Radiotherapy, Adjuvant1200717840.050 Why?
Heterocyclic Compounds, 3-Ring120242870.050 Why?
Anilides120244110.050 Why?
Valine120234080.050 Why?
Clinical Trials, Phase I as Topic120023260.050 Why?
Cohort Studies22021414950.040 Why?
Case-Control Studies12018221760.040 Why?
Chelating Agents120023870.040 Why?
Proto-Oncogene Proteins1201245140.040 Why?
Genetic Testing1201335370.040 Why?
Heme120023130.040 Why?
Karnofsky Performance Status120201660.040 Why?
Clinical Trials, Phase II as Topic120026290.040 Why?
Genes, Recessive120026230.040 Why?
Inflammation12019107740.040 Why?
Antibodies, Monoclonal, Murine-Derived120026940.040 Why?
Genes, Dominant120028520.040 Why?
Amyloid Precursor Protein Secretases120236200.040 Why?
Mammalian orthoreovirus 312018450.040 Why?
Survival Analysis32019100900.040 Why?
X Chromosome120028160.040 Why?
Disease Progression42016135100.040 Why?
Fatigue2201715520.040 Why?
Antiretroviral Therapy, Highly Active1200718970.040 Why?
Clinical Trials, Phase III as Topic120028570.040 Why?
Intention to Treat Analysis120194130.040 Why?
Switzerland120183240.040 Why?
Liver Neoplasms1201343170.040 Why?
France120184970.030 Why?
Tumor Burden2201418920.030 Why?
DNA, Mitochondrial120028650.030 Why?
Genetic Linkage1200223410.030 Why?
Nitroimidazoles120171170.030 Why?
Granulocyte-Macrophage Colony-Stimulating Factor120008910.030 Why?
Antigen Presentation1200112510.030 Why?
Leukocyte Count1201915960.030 Why?
Randomized Controlled Trials as Topic22023102120.030 Why?
New Zealand120163580.030 Why?
Ethanol1200213240.030 Why?
Drug Resistance1200115960.030 Why?
Multiple Myeloma2200651460.030 Why?
Epirubicin12014810.030 Why?
Body Image120206380.030 Why?
Gene Expression Regulation, Neoplastic2201385540.030 Why?
Early Termination of Clinical Trials12015690.030 Why?
Endpoint Determination120175900.030 Why?
Stomatitis120172710.030 Why?
Nausea120176790.030 Why?
T-Lymphocytes, Cytotoxic1200117840.030 Why?
Republic of Korea120165900.030 Why?
Drug Eruptions120173350.030 Why?
Antimetabolites, Antineoplastic120176460.030 Why?
Oncolytic Viruses120183440.030 Why?
Ifosfamide120142320.030 Why?
Bone Marrow Transplantation1200126930.030 Why?
Antineoplastic Agents, Alkylating120176170.030 Why?
Iron1200217930.030 Why?
Hematologic Diseases120174960.030 Why?
Lower Extremity1202112020.030 Why?
Alopecia120174120.030 Why?
Radiotherapy1200014980.030 Why?
United States12021723400.030 Why?
Australia1201612500.030 Why?
Exanthema120175030.030 Why?
Killer Cells, Natural1200122010.030 Why?
Affect1202014860.020 Why?
Neutropenia120178850.020 Why?
Benzamides1201713710.020 Why?
Comparative Genomic Hybridization120134730.020 Why?
Myelodysplastic Syndromes1200213940.020 Why?
Adolescent52023883260.020 Why?
Triazines120133110.020 Why?
Patient Selection2201442440.020 Why?
Consensus1202131240.020 Why?
Genes, ras120136540.020 Why?
Alanine120136090.020 Why?
Lymphocyte Activation1200154850.020 Why?
Predictive Value of Tests22019152660.020 Why?
Dendritic Cells1200127470.020 Why?
Hematologic Neoplasms1200118960.020 Why?
Qualitative Research1202030250.020 Why?
Disease Management1202025080.020 Why?
Immunosuppressive Agents1200141760.020 Why?
Specimen Handling120137020.020 Why?
Incidental Findings120136970.020 Why?
src-Family Kinases120115350.020 Why?
Prospective Studies42017544230.020 Why?
Workflow120138510.020 Why?
Time Factors32015399690.020 Why?
Alternative Splicing1201310930.020 Why?
Mutation12012300530.020 Why?
Pain1202250730.020 Why?
Europe1201434200.020 Why?
Administration, Oral1201540210.020 Why?
Diarrhea1201313180.020 Why?
International Cooperation1201314220.020 Why?
Exons1201223910.020 Why?
Pneumonectomy1201311190.020 Why?
Chronic Disease1200193190.020 Why?
Neoplasm Invasiveness1201435970.020 Why?
Models, Biological1200194690.020 Why?
Oligonucleotide Array Sequence Analysis1201337790.010 Why?
Child22023801580.010 Why?
Anti-Bacterial Agents1200274060.010 Why?
Early Detection of Cancer1201732010.010 Why?
Neoplasms22024221730.010 Why?
Severity of Illness Index12020158430.010 Why?
Postoperative Complications12024156330.010 Why?
Hematopoietic Stem Cell Transplantation1200056720.010 Why?
High-Throughput Nucleotide Sequencing1201336390.010 Why?
DNA Methylation1201343990.010 Why?
Immunohistochemistry12012110760.010 Why?
Head and Neck Neoplasms1201228940.010 Why?
Gene Expression Profiling1201394200.010 Why?
MicroRNAs1201338160.010 Why?
Phenotype12013165920.010 Why?
Reproducibility of Results12013201000.010 Why?
Transplantation, Autologous1200021150.010 Why?
Genetic Predisposition to Disease12013179040.010 Why?
Recurrence1200084660.000 Why?
Risk Factors12014742130.000 Why?
Drug Resistance, Neoplasm1200053050.000 Why?
Alcindor's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (280)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.